Published in Farmakol Toksikol on July 20, 1967
Antianginal drugs. Pharmacol Ther (1979) 0.78
[GABAergic mechanism of cerebrovasculareffect of mexidol]. Eksp Klin Farmakol (2010) 0.78
[GABAergic mechanism of the cerebrovascular effect of melatonin]. Eksp Klin Farmakol (2012) 0.78
[The effect of nimodipine on a local ischemic brain lesion]. Vestn Ross Akad Med Nauk (1998) 0.78
[Gabaergic mechanism of cerebrovascular and neuroprotective effects of afobazole and picamilon]. Eksp Klin Farmakol (2005) 0.77
[Electrophysiologic study of the anti-arrhythmic mechanism of action of phosphocreatine in acute myocardial ischemia and reperfusion]. Kardiologiia (1991) 0.77
[Cerebrovascular and antiaggregative effects of GABA-docosahexaenoyldopamine conjugate]. Eksp Klin Farmakol (2008) 0.77
[Local cerebral ischemia in rats induced by ligation of the middle cerebral artery]. Eksp Klin Farmakol (1997) 0.77
[Effects of antiarrhythmia agents and sympathetic regulation of the heart]. Vestn Akad Med Nauk SSSR (1982) 0.75
[Effect of nonachlazine on transmembrane ionic currents in the frog atrial trabeculae]. Biull Eksp Biol Med (1983) 0.75
[Correlation between the curare-like activity and adverse properties of a series of a series of diphenylcyclobutane dicarboxylic acid derivatives]. Farmakol Toksikol (1974) 0.75
[Dependence of calcium influx in squid axons on rhythmic excitation frequency]. Biofizika (1983) 0.75
[2-(2'-hydroxy 2'-substituted) ethyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazines--a novel group of substances with anti-arrhythmia activity]. Eksp Klin Farmakol (2003) 0.75
Antiarrhythmic properties of estrogens. Bull Exp Biol Med (2006) 0.75
[Bonnecor--a new anti-arrhythmia preparation]. Farmakol Toksikol (1990) 0.75
[Effect of inderal on the coronary blood circulation]. Farmakol Toksikol (1968) 0.75
On the mechanism of action of the antianginal drug nonachlazine on ischemic myocardium. Adv Myocardiol (1983) 0.75
[Relationship between the chemical structure and antiarrhythmic effect in a series of 10-acyl derivatives of 2-trifluoro substituted phenothiazines and esters of phenothiazine 2-carbamic acids]. Farmakol Toksikol (1971) 0.75
[The significance of central adrenergic processes in the mechanism of nitroglycerin action on the sympathetic tonus and vasomotor reflexes]. Biull Eksp Biol Med (1969) 0.75
[Effect of exogenous phosphocreatine on the size of experimental myocardial infarction]. Kardiologiia (1988) 0.75
[First clinical application of a new Soviet anti-arrhythmia preparation, a diethylamine derivative of ethmozin, in patients with various disorders of cardiac rhythm]. Kardiologiia (1982) 0.75
[Ethacizin: pharmacologic properties and prospects for clinical application]. Kardiologiia (1984) 0.75
[A new class-III antiarrhythmic preparation among the dicyclohexylamides of aminocarboxylic acids]. Vestn Ross Akad Med Nauk (1998) 0.75
[Anti-arrhythmia and antifibrillatory properties of dibenzazepine derivatives]. Kardiologiia (1986) 0.75
New aminocarboxamides with class III anti-arrhythmic activity. Arch Pharm (Weinheim) (1999) 0.75
[Activation of the sympathetic nervous system influences the antifibrillatory effect of class I antiarrhythmic drugs]. Eksp Klin Farmakol (2004) 0.75
[The mechanism of cordaron (amyodaron) action on cardiac blood supply]. Kardiologiia (1971) 0.75
[Pharmacology of ethmosine]. Farmakol Toksikol (1972) 0.75
[Effect of cardiocyclide on the electrophysiological parameters of heart in experiments with vagus nerve excitation in narcotized dogs]. Eksp Klin Farmakol (2005) 0.75
[Effect of nonachlasine on ATP, NAD-H, and NAD-H2 levels and activities of transaminases in cat myocardium during myocardial infarction]. Biull Eksp Biol Med (1982) 0.75
[Nature and functional significance of delayed postresuscitation hypoperfusion of the brain]. Anesteziol Reanimatol (1982) 0.75
[Clinical pharmacokinetics and hemodynamics of ethacizin in the acute period of myocardial infarct]. Farmakol Toksikol (1986) 0.75
[Effect of nonachlazine and oxyfedrine on coronary circulation in dogs]. Biull Eksp Biol Med (1977) 0.75
[Nonachlasine--a new drug for treatment of ischemic heart disease]. Kardiologiia (1975) 0.75
[Characteristics of the anti-arrhythmia effect of phosphocreatine in the acute stage of experimental myocardial infarction]. Kardiologiia (1988) 0.75
Ethacizin metabolism in humans. Xenobiotica (1989) 0.75
[Effect of the class III antiarrhythmic drug nibentan in vagotonic atrial fibrillation]. Eksp Klin Farmakol (2006) 0.75
[Binding of dicyclohexylamide derivatives of N-substituted aminocarboxylic acids with muscarinic cholinoreceptors and beta-adrenoreceptors]. Eksp Klin Farmakol (2003) 0.75
[Electrophysiologic research on the anti-arrhythmia properties of bonnecor--a new dibenzazepine derivative]. Kardiologiia (1986) 0.75
Ethmozine and ethacizine--new antiarrhythmic drugs with defibrillating properties. J Basic Clin Physiol Pharmacol (1996) 0.75
[Afobazole effect on heart rate variability in rats with different behaviors in the "open field" test]. Eksp Klin Farmakol (2009) 0.75
[Antifibrillatory and anti-arrhythmic action of 3-carbethoxyamino-5-dimethylamino-acetyl iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on models of myocardial ischemia]. Pharmazie (1985) 0.75
[Effect of nitroglycerin on the dimensions of the focal lesion in experimental myocardial necrosis]. Kardiologiia (1982) 0.75
[Mechanisms of the inotropic action of nonachlazine]. Farmakol Toksikol (1985) 0.75
[Antiarrhythimic properties of ethmozine]. Farmakol Toksikol (1970) 0.75
[Correlation between the anti-arrhythmia effect of ethacizin and pharmacokinetic parameters in a model of rhythm adoption by the heart]. Kardiologiia (1986) 0.75
[Use of mathematical methods of analysis of ECG data for evaluating the effectiveness of treatment of alcoholic cardiomyopathies with preparations of the phenothiazine group]. Kardiologiia (1986) 0.75
[The anti-arrhythmia activity of new dicyclohexylamide derivatives of N-substituted alpha-aminocarboxylic acids]. Eksp Klin Farmakol (1999) 0.75
[Comparative study of the anti-arrhythmic activity of cardiocyclide and nibentan in hypersympathotonia and acute myocardial ischemia]. Eksp Klin Farmakol (2002) 0.75
[Role of serotonin and histamine in the pathogenesis of various types of inflammation]. Patol Fiziol Eksp Ter (1978) 0.75
[Nonachlazine in solution as an arresting agent in stenocardiac attacks]. Farmakol Toksikol (1979) 0.75
[Calcium ion binding in somatic nerves during conduction of rhythmic excitation]. Fiziol Zh SSSR Im I M Sechenova (1984) 0.75
[Circulatory action and adverse effects of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog and cat]. Pharmazie (1985) 0.75
New 5-aminoacyl-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-ones with antiarrhythmic activity. Pharmazie (1997) 0.75
[Assessment of the influence of pharmacologic substances on pressor vasomotor reflexes in anesthetized animals]. Farmakol Toksikol (1977) 0.75
[Principles of modern drug therapy of ischemic heart disease]. Ter Arkh (1977) 0.75
[The anti-arrhythmic activity of the arylamides of alpha-hexamethyleneiminocarboxylic acids]. Farmakol Toksikol (1991) 0.75
[Hydrochlorides of N-hydroxyalkyl-alpha-piperidine carboxylic arylamides possessing antiarrhythmic activity]. Farmakol Toksikol (1985) 0.75
[New data on the mechanism of the action of nitrites on coronary circulation]. Kardiologiia (1967) 0.75
[Pharmacological and clinical study of the liquid drug form of nonachlazine]. Kardiologiia (1979) 0.75
[The role of vagal control in the action of propranolol on the chronotropic cardiac function]. Eksp Klin Farmakol (2008) 0.75
[Pharmacologic effect on the adrenergic mechanisms of heart blood supply regulation]. Kardiologiia (1967) 0.75
[Reflex responses in cardiac sympathetic nerves and their modification under the effect of morphine]. Biull Eksp Biol Med (1966) 0.75
[Use of computers for detecting the dynamics of changes in the cardiac adaptation reserves of alcoholism patients treated with nonachlazine]. Biull Eksp Biol Med (1982) 0.75
[An analysis of the mechanisms of the antianginal effect of nitroglycerin and morphine]. Farmakol Toksikol (1974) 0.75
[Antifibrillatory effect of antiarrhythmic drugs of various classes under conditions of activation of the parasympathetic nervous system]. Eksp Klin Farmakol (2005) 0.75
[Effect of phosphocreatine on the blood supply of the ischemic myocardium]. Fiziol Zh (1988) 0.75
[Comparative study of the electrophysiological properties of class iii medicinals (cardiocyclide, nibentan, sotalol) and evaluation of their efficacy in atrial fibrillation produced by auricular and vagal stimulation]. Eksp Klin Farmakol (2007) 0.75
[Current aspects of the search for and preclinical study of anti-arrhythmia agents]. Kardiologiia (1986) 0.75
[Characteristics of the protective action of ethacizin on the ischemic myocardium]. Biull Eksp Biol Med (1984) 0.75
[Differences in the efficiency of their interaction with membrane receptors of the dialkylaminoalkyl and dialkylaminoacyl derivatives of phenothiazine]. Biull Eksp Biol Med (1990) 0.75
[Pharmacology of ethacizin]. Farmakol Toksikol (1986) 0.75
Ultrastructure of Purkinje cells in the subendocardium and false tendons in early experimental myocardial infarction complicated by fibrillation in the dog. Virchows Arch B Cell Pathol Incl Mol Pathol (1989) 0.75
[The mechanism of nonachlazine on cardiac activity and blood supply]. Biull Eksp Biol Med (1975) 0.75
[Effect of nitroglycerin on the extent of experimental myocardial necrosis]. Biull Eksp Biol Med (1981) 0.75
[A first trial in the clinical study of bonnecor]. Farmakol Toksikol (1990) 0.75
[A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids]. Eksp Klin Farmakol (1994) 0.75
[Effect of antianginal agents with a beta-adrenostimulating component of their action on the ischemic myocardium]. Farmakol Toksikol (1982) 0.75
[Analysis of the mechanisms of the anti-arrhythmic action of marcaine and lidocaine]. Farmakol Toksikol (1984) 0.75
[Effect of antibiotics on D-serotonin-reactive structures]. Farmakol Toksikol (1986) 0.75
[Anti-inflammatory, analgesic and antipyretic properties of nonachlazine]. Farmakol Toksikol (1981) 0.75
[Apropos of the mechanism of action of monoamine oxidase-inhibitors on the coronary circulation]. Farmakol Toksikol (1966) 0.75
[The effect of novel class III anti-arrhythmia agents cardiocyclide and nibentan during activation of cardiac beta-adrenoreceptors]. Eksp Klin Farmakol (2003) 0.75
[Anti-arrhythmic properties of ethmosine (clinico-experimental study)]. Kardiologiia (1978) 0.75
[Pharmacokinetics and pharmacodynamics of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog]. Pharmazie (1985) 0.75
[Antiarrhythmic properties of 2-(2'-hydroxy-2')-substituted ethyl-1,2,3,4-octahydropyrrolo[1,2-a]pyrazines]. Eksp Klin Farmakol (2004) 0.75
[Ultrastructure of the Purkinje cells in the subendocardium and pseudo-tendons of the left ventricle in dogs with experimental infarct complicated by fibrillation]. Arkh Patol (1986) 0.75
[Anti-arrhythmia activity of estradiol valerate and estradiol nitrate]. Eksp Klin Farmakol (2003) 0.75
[Pharmacokinetics and pharmacodynamics of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the cat]. Pharmazie (1985) 0.75
[Antiarrhythmic effectiveness of 3-carbalkoxyamino-5-(omega-aminoacyl)-10,11-dihydro-5H-dibenz-[b,f]- azepines]. Pharmazie (1985) 0.75
[The importance of central monoaminergic mechanisms in the effect of pharmacologic substances on the reflex reactions of the heart]. Biull Eksp Biol Med (1967) 0.75
Receptor binding potencies of chlorpromazine, trifluoperazine, fluphenazine and their 10-N-substituted analogues. Biomed Biochim Acta (1988) 0.75
[Effect of nonachlazine on the processes of uptake and release of nordrenaline]. Farmakol Toksikol (1977) 0.75
[Characteristics of the anti-arrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-imino-dibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015)]. Pharmazie (1985) 0.75
[Comparison of the effect of ildamen and nonachlazin on the blood supply and activities of the heart]. Kardiologiia (1978) 0.75
[Effect of monoamine oxidase inhibitors on the content of catecholamines in different parts of the brain in cats]. Farmakol Toksikol (1968) 0.75
[A new group of anti-arrhythmia agents (the search, results and concept)]. Farmakol Toksikol (1990) 0.75
[Anti-arrhythmia agents: results and outlook]. Eksp Klin Farmakol (1995) 0.75